<DOC>
	<DOCNO>NCT00964041</DOCNO>
	<brief_summary>This parallel-group , placebo-controlled trial examine cognitive effect week 1 , 4 , &amp; 8 once-weekly oral D-cycloserine 50 mg add stable dose antipsychotic 8 week adult outpatient schizophrenia .</brief_summary>
	<brief_title>Once Weekly D-cycloserine Schizophrenia</brief_title>
	<detailed_description>In previous placebo-controlled trial , investigator demonstrate significant improvement negative symptom once-weekly D-cycloserine treatment . In addition , investigator find significant improvement memory consolidation follow first dose ; however , effect memory consolidation lose several week . The `` practice effect '' weekly measurement memory consolidation use repeat administration Logical Memory Test may result `` ceiling effect '' would obscure drug/placebo difference . In current study , investigator propose administer Logical Memory Test four-week interval ( week 1 , 4 8 ) avoid ceiling effect . Additionally measurement add negative symptom week 4 good characterize time course negative symptom improvement . Hypotheses : 1 . Assess effect single dose D-cycloserine 50 mg memory consolidation measure Logical Memory Test compare placebo . 2 . Assess persistence once-weekly D-cycloserine effect memory consolidation measure week 4 &amp; 8 . 3 . Assess effect repeat weekly dose D-cycloserine performance standard cognitive battery week 8 compare placebo . 4 . Assess effect weekly D-cycloserine dose negative symptom week 4 &amp; 8 compare placebo . 5 . Assess tolerability side effect weekly D-cycloserine compare placebo .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>1 . Male female 2 . Age 1865 year 3 . Diagnosis schizophrenia schizoaffective disorder , depress type 4 . Stable dose antipsychotic least 4 week . 5 . Able provide inform consent 6 . Able complete cognitive battery 1 . Current treatment clozapine 2 . Dementia 3 . Seizure disorder 4 . Unstable medical illness 5 . Active substance abuse 6 . Pregnancy , nursing , unwilling use appropriate birth control measure participation female fertile . 7 . Severe renal insufficiency ( Serum creatinine &gt; 1.5 mg/dL )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Cognitive Impairment</keyword>
	<keyword>Neuroplasticity</keyword>
	<keyword>D-cycloserine</keyword>
	<keyword>N-methyl-D-aspartate ( NMDA )</keyword>
	<keyword>Anti-Bacterial Agents</keyword>
	<keyword>Mental Disorders</keyword>
	<keyword>Psychotic Disorders</keyword>
	<keyword>Antitubercular Agents</keyword>
	<keyword>Schizophrenia Disorders Psychotic Features</keyword>
	<keyword>Schizoaffective Disorder</keyword>
</DOC>